Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
出版年份 2013 全文链接
标题
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
作者
关键词
-
出版物
Science Translational Medicine
Volume 5, Issue 209, Pages 209ra151-209ra151
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2013-10-31
DOI
10.1126/scitranslmed.3007218
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions
- (2013) K. M. Habegger et al. DIABETES
- A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?
- (2013) P. C. Butler et al. DIABETES CARE
- Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation?
- (2013) M. A. Nauck et al. DIABETOLOGIA
- Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
- (2012) Jun Wu et al. CELL
- Recent advances in incretin-based therapies
- (2012) David Russell-Jones et al. CLINICAL ENDOCRINOLOGY
- Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12DMouse Model
- (2012) Belinda Gier et al. DIABETES
- Effects of the dual PPAR-α/γ agonist aleglitazar on glycaemic control and organ protection in the Zucker diabetic fatty rat
- (2012) A. Bénardeau et al. DIABETES OBESITY & METABOLISM
- An Update in Incretin-Based Therapy: A Focus on Glucagon-Like Peptide-1 Receptor Agonists
- (2012) Krystal L. Edwards et al. Diabetes Technology & Therapeutics
- Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21
- (2012) Timo D. Müller et al. JOURNAL OF PEPTIDE SCIENCE
- Targeted estrogen delivery reverses the metabolic syndrome
- (2012) Brian Finan et al. NATURE MEDICINE
- GIP-Overexpressing Mice Demonstrate Reduced Diet-Induced Obesity and Steatosis, and Improved Glucose Homeostasis
- (2012) Su-Jin Kim et al. PLoS One
- GIP Does Not Potentiate the Antidiabetic Effects of GLP-1 in Hyperglycemic Patients With Type 2 Diabetes
- (2011) N. Mentis et al. DIABETES
- Effects of acute and chronic administration of GIP analogues on cognition, synaptic plasticity and neurogenesis in mice
- (2011) Emilie Faivre et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- GLP-1 and energy balance: an integrated model of short-term and long-term control
- (2011) Jason G. Barrera et al. Nature Reviews Endocrinology
- Glucose Intolerance and Reduced Proliferation of Pancreatic -Cells in Transgenic Pigs With Impaired Glucose-Dependent Insulinotropic Polypeptide Function
- (2010) S. Renner et al. DIABETES
- Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo
- (2010) S. Uhles et al. DIABETES OBESITY & METABOLISM
- GIP increases human adipocyte LPL expression through CREB and TORC2-mediatedtrans-activation of theLPLgene
- (2010) Su-Jin Kim et al. JOURNAL OF LIPID RESEARCH
- Charge inversion at position 68 of the glucagon and glucagon-like peptide-1 receptors supports selectivity in hormone action
- (2010) Jonathan W. Day et al. JOURNAL OF PEPTIDE SCIENCE
- A GIP Receptor Agonist Exhibits β-Cell Anti-Apoptotic Actions in Rat Models of Diabetes Resulting in Improved β-Cell Function and Glycemic Control
- (2010) Scott B. Widenmaier et al. PLoS One
- GIP: No Longer the Neglected Incretin Twin?
- (2010) R. N. Kulkarni Science Translational Medicine
- Exogenous Glucose-Dependent Insulinotropic Polypeptide Worsens Post prandial Hyperglycemia in T ype 2 Diabetes
- (2009) C. W. Chia et al. DIABETES
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
- (2009) Jonathan W Day et al. Nature Chemical Biology
- Targeted Ablation of Glucose-dependent Insulinotropic Polypeptide-producing Cells in Transgenic Mice Reduces Obesity and Insulin Resistance Induced by a High Fat Diet
- (2008) Matthew C. Althage et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started